Kai-Wen Lin

649 total citations
13 papers, 450 citations indexed

About

Kai-Wen Lin is a scholar working on Oncology, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Kai-Wen Lin has authored 13 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cognitive Neuroscience and 4 papers in Psychiatry and Mental health. Recurrent topics in Kai-Wen Lin's work include EEG and Brain-Computer Interfaces (4 papers), Epilepsy research and treatment (4 papers) and CAR-T cell therapy research (3 papers). Kai-Wen Lin is often cited by papers focused on EEG and Brain-Computer Interfaces (4 papers), Epilepsy research and treatment (4 papers) and CAR-T cell therapy research (3 papers). Kai-Wen Lin collaborates with scholars based in United States, New Zealand and South Africa. Kai-Wen Lin's co-authors include Selim R. Benbadis, W. Zheng, Zhiwei Huang, Ming Teh, Khek Yu Ho, Jimmy Bok Yan So, Khay Guan Yeoh, Mads S. Bergholt, Kayvan Najarian and Michael W. Sjoding and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Kai-Wen Lin

13 papers receiving 441 citations

Peers

Kai-Wen Lin
Omri Bar United States
Caiyun Wu China
Clemens Vass Austria
Jin Kyu Gahm United States
Omri Bar United States
Kai-Wen Lin
Citations per year, relative to Kai-Wen Lin Kai-Wen Lin (= 1×) peers Omri Bar

Countries citing papers authored by Kai-Wen Lin

Since Specialization
Citations

This map shows the geographic impact of Kai-Wen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai-Wen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai-Wen Lin more than expected).

Fields of papers citing papers by Kai-Wen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai-Wen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai-Wen Lin. The network helps show where Kai-Wen Lin may publish in the future.

Co-authorship network of co-authors of Kai-Wen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Kai-Wen Lin. A scholar is included among the top collaborators of Kai-Wen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai-Wen Lin. Kai-Wen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tolcher, Anthony W., Joshua Brody, Nishanthan Rajakumaraswamy, et al.. (2024). Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 30(14). 2954–2963. 13 indexed citations
2.
Odegard, Jared, Ahmed A. Othman, Kai-Wen Lin, et al.. (2024). Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 12(4). e008547–e008547. 8 indexed citations
3.
Santin, Alessandro D., Bradley R. Corr, Alexander I. Spira, et al.. (2024). Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer. Journal of Clinical Oncology. 42(29). 3421–3429. 20 indexed citations
4.
Burneo, Jorge G., David A. Steven, Dario J. Englot, et al.. (2024). Fellowship education in epilepsy in Latin America and Africa: Results of a survey. Epilepsy & Behavior. 163. 110161–110161. 1 indexed citations
5.
Shah, Manish A., David Cunningham, Jean‐Philippe Metges, et al.. (2021). Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. Journal for ImmunoTherapy of Cancer. 9(12). e003580–e003580. 36 indexed citations
6.
Rajakumaraswamy, Nishanthan, Anees M. Dauki, Michelle Kuhne, et al.. (2021). 380 GS-3583, a novel FLT3 agonist Fc fusion protein, expands conventional dendritic cells in healthy volunteers. Regular and Young Investigator Award Abstracts. A413–A414. 2 indexed citations
7.
8.
Sjoding, Michael W., et al.. (2018). Accounting for Label Uncertainty in Machine Learning for Detection of Acute Respiratory Distress Syndrome. IEEE Journal of Biomedical and Health Informatics. 23(1). 407–415. 49 indexed citations
9.
Chen, Zhijian, Jiahui Luo, Kai-Wen Lin, et al.. (2017). An Energy-Efficient ECG Processor With Weak-Strong Hybrid Classifier for Arrhythmia Detection. IEEE Transactions on Circuits & Systems II Express Briefs. 65(7). 948–952. 47 indexed citations
10.
Bergholt, Mads S., W. Zheng, Kai-Wen Lin, et al.. (2011). In Vivo Diagnosis of Esophageal Cancer Using Image-Guided Raman Endoscopy and Biomolecular Modeling. Technology in Cancer Research & Treatment. 10(2). 103–112. 120 indexed citations
11.
Lin, Kai-Wen & Selim R. Benbadis. (2009). Death and epilepsy. Expert Review of Neurotherapeutics. 9(6). 781–783. 5 indexed citations
12.
Benbadis, Selim R. & Kai-Wen Lin. (2008). Errors in EEG Interpretation and Misdiagnosis of Epilepsy. European Neurology. 59(5). 267–271. 103 indexed citations
13.
Lin, Kai-Wen, et al.. (2007). EEG Findings in the Persistent Vegetative State. Journal of Clinical Neurophysiology. 24(6). 433–437. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026